Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer
Among the three primary gynecological malignancies, ovarian cancer has the lowest incidence but the worst prognosis. Because of the poor prognosis of ovarian cancer patients treated with existing treatments, immunotherapy is emerging as a potentially ideal alternative to surgery, chemotherapy, and t...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2023-02-01
|
| Series: | Cancer Control |
| Online Access: | https://doi.org/10.1177/10732748231159706 |